Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Insulin potentiation therapy: a new concept in the management of chronic degenerative disease.

Ayre SG, Perez Garcia y Bellon D, Perez Garcia D Jr.

Med Hypotheses. 1986 Jun;20(2):199-210.

PMID:
3526099
2.

Cancer Drug Development: New Targets for Cancer Treatment.

Curt GA.

Oncologist. 1996;1(3):II-III.

PMID:
10387987
3.
4.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
6.

New concepts in extracellular signaling for insulin action: the single gateway hypothesis.

Bergman RN.

Recent Prog Horm Res. 1997;52:359-85; discussion 385-7. Review.

PMID:
9238859
7.
8.

[80 years' of internal medicine education at the medical school of the university in Belgrade (1922-2002)].

Micić J, Micić D.

Srp Arh Celok Lek. 2003 Jul-Aug;131(7-8):351-64. Serbian.

PMID:
14692153
9.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
10.

Insulin glargine.

Campbell RK, White JR, Levien T, Baker D.

Clin Ther. 2001 Dec;23(12):1938-57; discussion 1923. Review.

PMID:
11813930
11.

Cellular loci of sulfonylurea actions.

Lebovitz HE.

Diabetes Care. 1984 May-Jun;7 Suppl 1:67-71. Review.

PMID:
6376031
12.

The quest for normoglycaemia: a historical perspective.

Tattersall RB.

Diabet Med. 1994 Aug-Sep;11(7):618-35.

PMID:
7955986
13.

Potentiation of insulin stimulation of hexose transport by kallikrein and bradykinin in isolated rat adipocytes.

Goldman J, Pfister D, Vukmirovich R.

Mol Cell Endocrinol. 1987 Apr;50(3):183-91.

PMID:
3552783
14.

[Metabolic therapy with glucose-insulin-potassium. Historical outline].

de Micheli A.

Arch Inst Cardiol Mex. 2000 Nov-Dec;70(6):609-15. Spanish. No abstract available.

PMID:
11255721
15.
16.

Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data.

Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D.

CMAJ. 2009 Apr 14;180(8):821-7. doi: 10.1503/cmaj.090206. Epub 2009 Mar 24. Review.

17.

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.

PMID:
15669880
18.
19.

Lowering of glucose in critical care: a randomized pilot trial.

McMullin J, Brozek J, McDonald E, Clarke F, Jaeschke R, Heels-Ansdell D, Leppert R, Foss A, Cook D.

J Crit Care. 2007 Jun;22(2):112-8; discussion 118-9. Epub 2007 Jan 31.

PMID:
17548021
20.

Glucose-insulin-potassium therapy for acute myocardial infarction: what goes around comes around.

Gnaim CI, McGuire DK.

Am Heart J. 2004 Dec;148(6):924-30. No abstract available.

PMID:
15632873

Supplemental Content

Support Center